Michelle Luo
Impact in
-
- Inflammatory Bowel Disease
-
- Gastrointestinal motility and disorders
Papers in
- Genetics 18
- Inflammatory Bowel Disease 18
- Epidemiology 10
- Microscopic Colitis 9
- Co-authors
- Trevor Lissoos (4 shared papers)Nabeel Khan (2 shared papers)Lizheng Shi (1 shared paper)Jeffrey S. McCombs (1 shared paper)Bryan M. Johnstone (1 shared paper)Karen Lasch (3 shared papers)Sherry Shi (1 shared paper)James D. Lewis (2 shared papers)
- Journals
- Journal of Crohn s and Colitis (8 papers)Inflammatory Bowel Diseases (3 papers)Blood (2 papers)The American Journal of Gastroenterology (2 papers)Haemophilia (1 paper)
- Partner nations
- United StatesCanadaGreece
In The Last Decade
Michelle Luo
29 papers receiving 231 citations
Peers
Comparison fields: 5 of 52
- Genetics 123
- Gastroenterology 16
- Immunology 37
- Epidemiology 36
- Complementary and alternative medicine 6
Countries citing papers authored by Michelle Luo
This map shows the geographic impact of Michelle Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Luo more than expected).
Fields of papers citing papers by Michelle Luo
This network shows the impact of papers produced by Michelle Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Luo. The network helps show where Michelle Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 44 | |
| 2 | 2017 | 36 | |
| 3 | 2023 | 29 | |
| 4 | 2019 | 15 | |
| 5 | 2000 | 14 | |
| 6 | 2018 | 12 | |
| 7 | 2022 | 7 | |
| 8 | Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn's Disease. | 2018 | 7 |
| 9 | 2022 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2019 | 6 | |
| 12 | 2019 | 6 | |
| 13 | Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial. | 2005 | 5 |
| 14 | 2023 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2018 | 4 | |
| 19 | [Study on inhibitory effect of ampelopsin on melanoma by serologic pharmacological method]. | 2001 | 4 |
| 20 | 2006 | 2 |
About Michelle Luo
Michelle Luo is a scholar working on Genetics, Epidemiology, Immunology, Pediatrics, Perinatology and Child Health and Hematology, having authored 33 papers that have together received 233 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (18 papers), Microscopic Colitis (9 papers), Biosimilars and Bioanalytical Methods (8 papers), Pharmaceutical studies and practices (4 papers), Eosinophilic Esophagitis (2 papers), Blood properties and coagulation (2 papers), Adolescent and Pediatric Healthcare (1 paper) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Genetics (123 citations), Gastroenterology (16 citations), Immunology (37 citations), Epidemiology (36 citations) and Complementary and alternative medicine (6 citations). Michelle Luo has collaborated with scholars based in United States, Canada and Greece. Frequent co-authors include Trevor Lissoos, Nabeel Khan, Lizheng Shi, Jeffrey S. McCombs, Bryan M. Johnstone, Karen Lasch, Sherry Shi, James D. Lewis, Yash Shah and Rajeev Ayyagari. Their work appears in journals such as Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, Blood, The American Journal of Gastroenterology and Haemophilia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.